ST ELEVATION MYOCARDIAL INFARCTION: AN EXPERIENCE AT LADY READING HOSPITAL PESHAWAR, PAKISTAN

Abstract

ABSTRACT OBJECTIVE: To find out the clinical characteristics, treatment offered and outcome of patients with ST elevation myocardial infarction (STEMI) admitted to cardiology unit Lady Reading Hospital (LRH), Peshawar, Pakistan. METHODS: This retrospective observational study was conducted in Cardiology Unit, LRH, Peshawar, Pakistan by analyzing record of all diagnosed STEMI patients of age >18 years, from 1st January to 31 December 2013. RESULTS: Total number of patients admitted with STEMI were 1733 (46.02% of total coronary artery disease admission). Of all these patients with STEMI, fibrinolytic therapy with streptokinase were given to 1380 (79.6%) patients, while 343 (19.8%) were late for fibrinolytic therapy or having some contraindication to fibrinolytic therapy. Ninety four (5.4%) patients received primary or rescue percutaneous coronary intervention (PCI). Out of 1733 patients, males were 1085 (62.60%), female were 648 (37.40%), mean age was 57.42±8.7 years, diabetes was found in 458 (26.39%) cases, hypertension in 679 (39.18%) cases, smokers were 183 (10.5%). Family history of coronary artery disease (CAD) was found in 205 (11.82%) cases, past history for CAD was present in 305 (17.5%) patients and anterior wall myocardial Infarction & new onset left bundle branch block was found in 790 (45%) cases. In-hospital mortality was 158 (9.1%). CONCLUSION: About 46% of patients admitted with CAD were having STEMI, of them 80% receive streptokinase while only 5.4% were subjected to primary or rescue PCI. In-hospital mortality is about 9%. Anterior wall MI was the most frequent AMI. KEY WORDS: Coronary Artery Disease (MeSH), Streptokinase (MeSH), Myocardial Infarction (MeSH), Percutaneous Coronary Intervention (MeSH), Hospital Mortality (MeSH), Thrombolytic Therapy (MeSH)